NutriBand (NTRB) Debt Ratio (2016 - 2026)

NutriBand (NTRB) posted Debt Ratio of 0.0 for Q2 2026, down 8.92% sequentially from 0.0 in Q1 2026, and down 49.42% YoY from 0.01 in Q2 2025.

NutriBand (NTRB) Debt Ratio (2016 - 2026) Analysis & Trends

NutriBand has reported Debt Ratio for 10 years, with the latest figure at 0.0 in Q2 2026.

Quarterly Debt Ratio fell 49.42% year-over-year to 0.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.0 (down 49.42% YoY) and the FY2026 annual result came in at 0.0, down 39.02% from the prior year.
Debt Ratio fell to 0.0 in Q2 2026 per NTRB's latest filing, from 0.0 in the prior quarter.
Over five years, Debt Ratio peaked at 0.01 in Q2 2023 and troughed at 0.0 in Q2 2026.
A 5-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2024 and 2025: Debt Ratio plunged 55.3% in 2024, then soared 74.0% in 2025.
Over 5 years, Debt Ratio stood at 0.01 in 2022, then increased by 0.96% to 0.01 in 2023, then slumped by 49.12% to 0.01 in 2024, then retreated by 2.72% to 0.0 in 2025, then declined by 12.43% to 0.0 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	138.93 Bn	131.08 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.11 Bn	78.11 Bn	3.93 Bn	0.05
3	Argenx Se	65.43 Bn	60.25 Bn	1.37 Bn	-
4	Moderna	56.09 Bn	50.96 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	-
7	BioNTech SE	27.68 Bn	9.29 Bn	668.28 Mn	0.03
8	Insmed	27.49 Bn	26.32 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	0.47
10	NutriBand	51.91 Mn	47.90 Mn	196,801.00	0.00

Download Data